Targeted radiation zaps tumors, could keep breast cancer drugs working longer
NCT ID NCT06925984
Summary
This study is for women with a specific type of advanced breast cancer (ER+/HER2-) whose current hormone-based medications are starting to fail at 1-3 spots in the body. Researchers want to see if using very precise, high-dose radiation (called SBRT) on just those few growing tumors can help patients continue their current medication for a longer time, delaying the need to switch to stronger treatments like chemotherapy. The main goal is to measure how many patients can avoid changing their main cancer drugs for at least 6 months after the radiation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLIGOPROGRESSIVE METASTATIC DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AZ Groeninge
RECRUITINGKortrijk, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
AZ Sint-Maarten
RECRUITINGMechelen, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU UCL Namur - Site Saint Elisabeth
RECRUITINGNamur, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jules Bordet Institute
RECRUITINGBrussels, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UZ Gent
RECRUITINGGhent, Belgium
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.